Table of Content

Executive Summary
Key Questions This Study Will Answer
6 Big Themes for Precision Medicine
Precision Medicine—Regional Market Overview
Precision Medicine Vendor Landscape by Major Market Clusters
Precision Medicine Readiness of Major Countries
Key Insights
Precision Medicine in the Wake of COVID-19

Research Scope, Definitions, and Segmentation
Research Scope
Personalized Vs Precision Medicine
Precision Medicine Categories
Patient Stratification—Data Volume, Sources, and Adoption
Precision Medicine—Key Segments and Data Sources

Current and Future State of Precision Medicine
Global Precision Medicine Market—Macro to Micro Visioning
Changing Modalities of Innovative Drugs
Precision Medicine in the Late-stage Clinical Trials Pipeline
Major Pharmacogenomics Biomarkers
Precision Medicine Vendor Landscape

Precision Medicine Market Projections (2019–2025)
Scenario Contingent Projections for Core Precision Medicine Segment
Forecast Assumptions for Core Precision Medicine Segment— Optimistic Scenario
Forecast Assumptions for Core Precision Medicine Segment— Pessimistic Scenario
Core Precision Medicine Segment—Revenue Forecast Scenario Analysis
Core Precision Medicine Segment—Revenue Forecast by Subsegments
Forecast Assumptions—Core Precision Medicine Key Subsegments
Forecast Assumptions—Core Precision Medicine Key Subsegments (continued)

Precision Medicine Cluster Benchmarking by Major Countries
Select Countries’ Readiness for Precision Medicine
Factors Consideration for Precision Medicine Country Readiness Index
Country Readiness for Precision Medicine—US
Country Readiness for Precision Medicine—EU and UK
Country Readiness for Precision Medicine—APAC

Growth Opportunities in Precision Medicine
Major Growth Opportunities

Opportunity Analysis—CDx and Biomarker-based Targeted Therapeutics (TRx)
Growth Opportunity 1—CDx and Biomarkers-based TRx
Precision Medicine Clinical Trials Trends in Major Regions
Top Areas of Companion Biomarker Research
New Clinical Trial Designs in the Era of Precision Medicine
New Clinical Trial Designs in the Era of Precision Medicine (continued)
Select Countries’ TRx and CDx Readiness Index

Opportunity Analysis—Genomics Technologies for Precision Diagnostics
Growth Opportunity 2—Genomics Technologies for Precision Diagnostics
Precision Medicine Patient Stratification by Omics/Diagnostic Factors
Level of Adoption of Select Novel Technologies and Approaches
Genomics Technologies for Precision Diagnostics
Select NGS Vendor Landscape
Select Countries’ Omics Research Readiness Index

Opportunity Analysis—Precision Medicine Informatics
Growth Opportunity 3—Precision Medicine Informatics Solutions
Precision Medicine Informatics Market Landscape
Precision Medicine Informatics Market Size
C2A: Xifin—Precision Medicine Informatics for MDx
Select Countries’ eHealth Readiness Index

Key Conclusions
Key Conclusions
Legal Disclaimer

Appendix
List of Exhibits